Document ID: FDA-2014-N-0189-4712
Agency: fda
Document Type: Supporting & Related Material
Title: 
Posted Date: 2014-06-16T04:00Z

Comment Info: =================

General Comment:Dear Mr. Zeller:
             I am writing as a consumer of e-cigarettes to request an extension of the comment period for the Food and Drug Administration's ("FDA") Proposed Rule Deeming Tobacco Products to be Subject to the Federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking and Prevention and Tobacco Control Act (the "Proposed Rule") published at 79 Fed. Reg. 23,142 and Federal Register No. 2014-09491.  I'm asking as a individual consumer of e-cigarettes for an extension for the comment period of the Proposed Rule  to be extended for an additional 105 days, from the current 75 days for a total of 180 days. 
     This Proposed Rule brings up a number of issues and questions that are very important and relevant to me, and as a customer of e-cigarettes The Proposed Rule will have a significant impact on me.  In the Proposed Rule it asks many different questions I feel the need to respond, giving my thoughts and comments to many of these issues, but with my limited time to devote to the research and giving my thoughtful comments on these very important questions,  I find my time  is very limited.  I have already spent many hours reading, dissecting, trying to digest these issues, and they do take time to get threw.  I don't think its  unreasonable to extend the comment period 105 days for a total of 180 days for the public comment, considering it took many years for the FDA to come up with this rule, and this is the only opportunity for us consumers to provide our feedback for something that will highly effect our lives.
     I 100% believe e-cigarettes have saved my life, and feel very strongly in e-cigarettes as being a viable alternitive  to combustable cigarettes. In my comment I want to beable to provide my personal story, science and evidence-based responses to your many questions, so you at FDA can take my comment into serious  account.  I know that the FDA has the authority under 21 CFR 10.40  to extend the time frame of the comment period, and has done this in the past on many occasions. I ask you to exercise your authority for this very important issue, so all the shareholders will have the opportunity to have time to submit well informed comments on this proposed regulations. 

Thank you for your time and consideration of my request.